Newsletter | April 3, 2024

04.03.24 -- Reducing Clinical Holds On CGT: Approaches For Sponsors And The FDA

SPONSOR

Setting the Standard in Streamlined Scale-Up

Streamline revalidation and optimization from the start by leveraging decades of demonstrated expertise in scalable upstream and downstream solutions. Designed with scalability in mind, our range of cell culture bioreactors, single-use bags, media, and reagents enable seamless process transfer to larger volumes. Throughout downstream processing, drive cost-efficiency with clarification and purification technologies that improve yield and maintain quality. And protect your product’s performance with preassembled storage solutions. Learn more.

FEATURED EDITORIAL

Reducing Clinical Holds On CGT: Approaches For Sponsors And The FDA

There is a large proportion of clinical trials for cell and gene therapies that the FDA places on clinical hold. Why is this, and what can sponsor companies and the FDA do differently?

Why Clinical Requirements Change: Discussing Pre-IND Meeting Pathways

Dr. Peter Marks describes how clinical requirements can change after the FDA and a company agree on a pathway during a pre-IND meeting and how the company might recover as a result.

INDUSTRY INSIGHTS

EU GMP Annex 1: Impact On Cleaning And Disinfection

Delve into the current emphasis on separate cleaning and disinfecting steps, which reflects current best practices, and the most up-to-date rewrite of the EU Annex 1.

Comparability Study Of An Ion Exchange Monolith And Affinity Resin

A side-by-side comparison was performed using a CIMmultus SO3—1 mL (2 µm) column and a commercially available affinity resin that binds several AAV serotypes.

How To Develop A Cell Therapy Manufacturing Roadmap

Craft a flexible manufacturing roadmap, a dynamic tool evolving with automation needs and processes. Vital for clarity, it maps the entire process, answering key questions for effective development.

Biopharmaceutical Packaging Solution Advancements And Considerations

Explore how to develop a strong packaging system, and why a reliable supply chain is critical for drug substance and drug product transport.

Design-Build Cleanroom Projects: A Proven Risk Mitigating Methodology

Learn about the rising demand for cleanrooms in the biopharmaceutical industry, factors driving cleanroom design, building in flexibility, the role of critical path assessments, and more.

Optimizing DNA Digestion Economics In Viral Vector Gene Therapy

Benzonase endonuclease is a high-quality product that delivers value to viral vector processes. Here, we highlight an optimization strategy and process economics of DNA digestion in viral vector purification.

A More Human-Relevant Model To Advance AAV-Based Gene Therapies

Uncover details about a liver-chip that offers a more human-relevant way of testing viral vectors compared to conventional models and why it is a promising tool for advancing AAV gene therapy.

Modeling And Online Estimation Of kLa And P/V

Examine continuous models of oxygen, kLa, and specific power input (power per volume or P/V) in 250mL and 5L bioreactors to scale up and compare bioreactor performance metrics.

Assay For Rapid Lot-Release Testing In Cell Therapies

See how PCR-based Mycoplasma detection assays can provide a rapid alternative to culturing with comparable sensitivity, specificity, and species range that can facilitate quick decision-making.

SPONSOR

Bringing 400+ mRNA experts to Boston this July, the 4th mRNA-Based Therapeutics Summit returns to share exclusive scientific and strategic insights spanning the end-to-end of mRNA drug development. Select your sessions from 4 tracks of content dedicated to Discovery, Translation, Clinical Development or CMC, and join the Next Generation mRNA Delivery Day or Regulatory Affairs Strategy Day to maximize your learnings. See the program

SOLUTIONS

Measure The Size And Concentration Of Nanoparticles In Real Time

Orthogonal Method For Testing RCAAV

Tumor-Infiltrating Leukocytes: Optimized Solutions For TIL Research

Accelerating The Development Of New Protein Therapeutics

Biopharma Manufacturing Solutions

Quantum Flex: Where Cells Thrive

SPONSOR

Stem cells are the backbone of many allogeneic therapies and where they come from affects development and supply chain logistics, particularly cryopreservation. What temperatures are ideal to maintain product potency? How do you build a reliable cold chain? How do you work with existing infrastructure to allow for an “off-the-shelf” therapy? Don’t miss the next Cell & Gene Live digital event! Registration is free thanks to the support of Charter Medical and Bio-Techne.

Connect With Cell & Gene: